An increasing number of British people are traveling abroad for medical care, as the UK’s National Health Service (NHS) continues to struggle to serve patients amid nursing strikes and budget cuts. Exacerbated by the COVID-19 pandemic and still feeling the after effects, NHS waiting lists in England alone now stand at a record seven million. That’s seven million people who are awaiting “routine, or non-urgent, treatment”, like hip replacements, eye care and gallbladder surgery. The situation has become so severe that the chairman of the British Medical Association, Professor Philip Banfield, has described it as a “national scandal”. Talking to Sky News, Professor Banfield said: “What the pandemic has done is aggravate a situation that was deteriorating, and we have been highlighting for ten years or more so if you look at the waiting list the figures had gone from 2.6 to 4.4 million before the pandemic. It has gone over seven million now. This is an absolute national scandal.” Professor Banfield’s comments come after the Royal College of Nursing said twice as many of its members were preparing to go on strike in February if talks with the UK government remain at a stalemate. The UK government says nurses have been offered a "fair" pay deal and it has accepted the recommendations of the independent pay review body "in full". As a result of the record-high waiting times, many Brits are opting to pay for their treatment privately, be it at home or abroad. Indeed, data shows the number of people in the UK searching Google for the term “private healthcare” has risen significantly to hit a record high. Meanwhile, figures from the Private Healthcare Information Network reveal the number of people self-paying for private acute care has increased by more than a third versus before the pandemic. Here at France Surgery, it is certainly something we’ve seen, too, with increased demand from UK patients seeking cardiology care and orthopedic surgery. “Before Brexit, English people came to France for healthcare purposes because they were reimbursed by the NHS. Now, they come to France because of the skyrocketing waiting lists in the UK,” said Carine Briat-Hilaire, chief executive and co-founder of France Surgery.
By replacing 30 minutes of daily social media use with physical activity, you will feel happier, new research suggests. According to the new study, switching social media for exercise for just two weeks can have a positive impact. The research team from the Mental Health Research and Treatment Center at Ruhr-Universität Bochum in Germany, headed up by assistant professor Julia Brailovskaia, Ph.D., reported that participants who swapped social media for exercise felt more satisfied, less depressed, and less stressed by the COVID-19 pandemic than their peers in a control group. Furthermore, the positive effects of the two-week period lasted for up to six months after the study concluded. “Given that we don’t know for certain how long the coronavirus crisis will last, we wanted to know how to protect people’s mental health with services that are as free and low-threshold as possible,” Brailovskaia said in a statement. “This shows us how vital it is to reduce our availability online from time to time and to go back to our human roots,” she added. “These measures can be easily implemented into one’s everyday life and they’re completely free – and, at the same time, they help us to stay happy and healthy in the digital age.” *image courtesy of Irina L from Pixabay
They are known to be able to sniff out illegal drugs and even cancer, but now a new study suggests sniffer dogs can also detect COVID-19 among airline passengers. Perhaps even more remarkable is the study, conducted by researchers in Finland, also found that once trained, dogs are as acuurate at sniffing out COVID-19 as a PCR nose and throat swab test. "Our preliminary observations suggest that dogs primed with one virus type can in a few hours be retrained to detect its variants," added Anu Kantele, a professor of infectious diseases at the Faculty of Medicine at the University of Helsinki, Finland, and colleagues. For the study, the researchers took four dogs previously trained to detect illegal drugs, dangerous goods and cancers, and trained them to recognise SARS-CoV-2 – the virus that causes COVID-19. To do so, the study team used swab samples from 114 people who had tested positive for the virus on a PCR swab test, including 28 with no symptoms, and from 306 negative tests. Remarkably, the dogs were able to successfully detect 92% of infected people and 91% of uninfected people. The dogs' noses were then put to the test in a live environment at Helsinki-Vantaa International Airport in Finland between September 2020 and April 2021. The dogs correctly identified 296 (99%) of 300 passengers with negative PCR results. Read the full release at BMJ Global Health. *Image: Sniffer dogs at Melbourne Airport doing a demonstration, licensed under the Creative Commons Attribution-Share Alike 2.0 Generic license.
One of the most distinctive symptoms of COVID-19, the disease that can arise from the SARS-CoV-2 virus, is loss of taste and smell. This symptom can even affect people for weeks and months after they have developed the disease. Now, new research provides some insight into why this is the case. Originally thought to be related to damage of the olfactory nerves, the decreased or altered sense of smell is called olfactory dysfunction. However, according to the new research published this week in The Laryngoscope, loss of smell due to COVID-19 may also be because of swollen and blocked nasal passages. “Initially, we noticed a pattern in patients with COVID-19 that they lost their sense of smell and taste. We noticed these findings could be used as an indicator of whether or not a patient had COVID-19, but we thought it had to do with the olfactory nerve,” said Dr. Anjali Bharati, an ER physician at Lenox Health Greenwich Village in New York, NY. However, the researchers discovered that a contributing factor of the loss of smell and taste is due to the tissues instead of nerves. The good news is that cells recycle and heal much more easily than nerve damage. “Nerve damage is a more serious thing. The question becomes ‘does it recover?’” said Bharati. “This news involves the physical makeup of the nose, like the nasal passage and the back of the throat. Nerve damage is part of the brain, which is more disconcerting than the nasal passages.” *Image credit: Photo by doTERRA International, LLC via Pexels
Initially, when the COVID-19 outbreak first happened, many thought the SARS-CoV-2 virus caused mainly respiratory problems. And while that assumption still holds true, new research shows that the disease can actually impact multiple organs in a person's body. The new study, the results of which appear in the BMJ, sought to discover whether adults develop other health conditions after a SARS-CoV-2 infection. For the research, a team led by Dr. Ken Cohen, executive director of translational research at Optum Labs, studied the health insurance records of 133,366 adults aged 65+ in the United States who had received a COVID-19 diagnosis before April 1, 2020. The researchers compared the records to individuals who did not have COVID-19 in 2019 or 2020 and individuals who had a lower respiratory tract infection but not COVID-19. The team then identified new conditions occurring 3 weeks or more after each participant’s COVID-19 diagnosis. Of those individuals who had a SARS-CoV-2 infection in 2020, 32% sought medical attention for a new or persistent condition. This was 11% higher than the comparison group from 2020. Among the new or persistent conditions were respiratory failure, fatigue, high blood pressure, memory issues, kidney injury, mental health-related diagnoses, hypercoagulability and cardiac rhythm disorders. Dr. Alicia Arbaje, director of Transitional Care Research at Johns Hopkins Medicine and a clinician at the Johns Hopkins Bayview Medical Center in Baltimore, said: “I think this work is significant. First, because it focuses on older adults, and this is the population that’s most likely to demonstrate long-term effects from this infection, and so I think it’s important and timely given the phase of the pandemic that we’re in.” [Related reading: Long Covid may hinder women's response, recovery from exercise] *Image by Michal Jarmoluk from Pixabay
Sharks could potentially help in the fight against COVID-19, new research suggests. According to the study by researchers from University of Wisconsin-Madison, the University of Minnesota and biomedical company Elasmogen, a biomedical company in Scotland, antibody-like proteins derived from sharks' immune systems can prevent SARS-CoV-2, the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells. The small, unique shark cells, known as VNARs, are around one-tenth the size of human antibodies, which allows them to reach even the tiniest of areas. The researchers found the VNARs can bind to infectious proteins in unique ways that bolster their ability to halt infection. Intriguingly, they were not just effective against SARS-CoV-2 , but also SARS-CoV-1, which caused the first SARS outbreak in 2003. While the researchers say their findings will not help in the fight against the ongoing COVID-19 pandemic, as treatments using shark VNARs simply aren't yet available, they could hold some promise in the face of future coronavirus outbreaks. "The big issue is there are a number of coronaviruses that are poised for emergence in humans," says Aaron LeBeau, a University of Wisconsin-Madison professor of pathology who helped lead the study. "What we're doing is preparing an arsenal of shark VNAR therapeutics that could be used down the road for future SARS outbreaks. It's a kind of insurance against the future." The team published its findings in Nature Communications. *image courtesy of Andrea Bohl from Pixabay
New research has found that being infected with SARS-CoV-2, the virus that can cause COVID-19, can trigger an immune response which lasts well after the initial infection and recovery, even if the person experiences mild symptoms or is asymptomatic. Infection with a virus causes our bodies to unleash proteins called antibodies which are designed to protect our cells from the foreign invaders (the virus). In some circumstances, however, these antibodies can attack the body's own organs and tissues. According to the research conducted by Cedars-Sinai, people who have had a prior SARS-CoV-2 infection, have a wide variety of autoantibodies up to six months after they have fully recovered, including some which can cause injury to organs and tissues. The study is the first to report not only the presence of elevated autoantibodies after mild or asymptomatic infection but their persistence over time. "These findings help to explain what makes COVID-19 an especially unique disease," said Justyna Fert-Bober, Justyna Fert-Bober, PhD, research scientist in the Department of Cardiology at the Smidt Heart Institute and co-senior author of the study. "These patterns of immune dysregulation could be underlying the different types of persistent symptoms we see in people who go on to develop the condition now referred to as long COVID-19," Fert-Bober added. The research has been published in the Journal of Translational Medicine. *Image by leo2014 from Pixabay
The unprecedented events of the last two years have certainly taken their toll on people's mental health. An ongoing health pandemic, disrupted lives and sporadic lockdowns have led to heightened levels of stress and anxiety. Now, new research reveals how owning a dog can has been beneficial to many people's mental health during the COVID-19 outbreak. According to the study by a team of researchers from Nestlé Purina Research in Saint-Louis in Missouri, United States, dog owners reported less depression and felt they had more social support compared with a control group during the COVID-19 pandemic. Speaking with Medical News Today, Dr. Francois Martin, lead author and section leader of the Behavior and Welfare Group at Nestlé Purina Research, said: “The context of the COVID-19 pandemic offered a unique opportunity to better understand how dogs may provide social support for their owners, buffer heightened symptoms of stress, anxiety, and depression, and contribute to happiness.” The researchers say their study shows that owning a dog helped protect pet owners from some of the negative psychological impacts of the pandemic. They also say that it adds to the scientific evidence that dogs provide positive support to their owners during hard times. “We also found that dog owners had significantly lower depression scores than potential dog owners, but the two groups had similar anxiety and happiness scores,” Dr. Martin added. The results from this observational study appear in the journal PLOS ONE. *Image by Sven Lachmann from Pixabay
To aid in the fight against the coronavirus pandemic, researchers have developed an experimental chewing gum that neutralizes SARS-CoV-2 - the virus that causes COVID-19 – in the mouth. Symptomatic and asymptomatic people with COVID-19 carry a high SARS-CoV-2 viral load in their saliva. This viral load is one of the main ways that the SARS-CoV-2 spreads from person to person. Therefore, neutralizing this viral load while it's still in the mouth could be a formidable way to curb the spread of the disease. That's why researchers, led by Penn Dental Medicine in Philadelphia, PA, created a chewing gum from plant-based materials that could reduce the SARS-CoV-2 viral load in saliva. Speaking to Medical News Today, Henry Daniell, Ph.D., vice-chair and W.D. Miller Professor in the Department of Basic & Translational Sciences at Penn Dental Medicine in Philadelphia, PA, lead author of the study, said: “SARS-CoV-2 replicates in the salivary glands, therefore, debulking viruses in the oral cavity should decrease reinfection of [people with a SARS-CoV-2 infection], in addition to prevention of transmission.” “So,” Dr. Daniell continued, “[Angiotensin-converting enzyme 2 (ACE2)] chewing gum should provide people with COVID-19 time to build immunity and help reduce disease severity, which depends on viral load.” The current study appears in Molecular Therapy. Image by davidgaigg from Pixabay
In rare cases – estimated to be around 4-6 of every one million people - some individuals who receive the AstraZeneca COVID-19 vaccine develop blood clots that can pose a risk to their health. Now, scientists believe they have discovered the trigger as to why this happens. The team – from Cardiff in Wales and the United States – have shown how a protein in the blood is attracted to a key component of the vaccine like a magnet. This attraction invokes an immune response that can see blood clots form. However, all of this relies on a series of unlucky events, which is why the number of people who experience such clots is so low. Prof Alan Parker, one of the researchers at Cardiff University, told BBC News: "The adenovirus has an extremely negative surface, and platelet factor four is extremely positive and the two things fit together quite well." He added: "We've been able to prove the link between the key smoking guns of adenoviruses and platelet factor four. "What we have is the trigger, but there's a lot of steps that have to happen next." The scientists' study is published in the journal Science Advances. *Image by Angelo Esslinger from Pixabay
A new deal between a medtech start-up and a 3D printing technology firm will see the latter’s innovative solutions made available across French hospitals. The agreement between French medtech start-up Bone 3D and Stratasys, a polymer 3D printing solutions provider, will afford hospitals direct access to an immediate, localised way of 3D printing essential medical equipment, medical devices and patient-specific anatomical models. Healthcare providers can sub-contract 3D printing hardware and services from Bone 3D, granting them the direct means to fulfil their own production needs on-site, as well as receive dedicated ongoing support from Bone 3D technicians. Jérémy Adam, CEO and founder, Bone 3D said: “Early on in the COVID-19 pandemic, the world witnessed the importance of 3D printing first-hand as it provided a swift and direct means of producing vital PPE to equip frontline healthcare workers, ventilator parts and other critical medical equipment. “However, beyond that, the versatility of 3D printing has seen huge demand from hospitals and medical institutions for a means to create maintenance parts, rehabilitation parts and medical devices. Our Hospifactory initiative will ensure that some of the market’s most advanced 3D printing technologies are made accessible exactly where and when they are needed by surgeons and clinicians across the French hospital network.” The latest partnership between Stratasys and Bone 3D follows last year’s deployment by Bone 3D of 60 Stratasys FDM 3D printers in the AP-HP in Paris, to support the frontline fight against COVID-19. *Image by krzysztof-m from Pixabay
A large French study involving 22 million people has shown that COVID vaccines dramatically reduce a person’s risk of being severely impacted by the disease. While being vaccinated doesn’t guarantee you won’t catch COVID or indeed become ill, it does, however, reduce your risk of being hospitalised or dying by as much as 90 per cent. The study, published Monday, also found two-dose vaccines, such as Pfizer-BioNTech, Moderna and Oxford-AstraZeneca, protect against the worst effects of the so-called Delta variant. For people aged 75 and older, such vaccines offered 84 per cent protection. This figure rose to 92 per cent for people 50 to 75. The results were the same for each vaccine manufacturer. “The vaccine was never really intended to stop the disease,” says Dr. Ulysses Wu, Hartford HealthCare’s System Director of Infection Disease and Chief Epidemiologist. “It was a very nice side effect that we were preventing disease, but it’s main purpose is to prevent the morbidity and mortality should we get the disease. It was really to take a deadly disease and turn it into the common cold.” The study was conducted by a scientific group set up by France’s health system (Epi-Share), its national insurance fund (l’Assurance Maladie) and its medicine agency (ANSM). N.B. The Johnson & Johnson vaccine (Janssen) was not included in the research due to an insufficient number of patients for comparison. * Image by Surprising_Shots from Pixabay
French President Emmanuel Macron has announced that the state will fund psychology appointments in the country starting next year. Speaking about the policy on Tuesday, President Macron acknowledged the psychological impact of government Covid restrictions, as well as past failures to make mental health a priority. President Macron announced several measures during a conference with professionals who work in the sector. As the coronavirus proliferated across France, “we didn't want to see the importance of mental health, and we got hit in the face with the fact that health is all-encompassing,” Macron said. “The consequences of the pandemic are just as tangible in mental health” as in physical health. He highlighted a spike in the number of children seeking psychological treatment, as well as a growing number of attempted suicides, notably among teenagers. According to President Macron, around 20% of French people suffer from depression, Under the new plans, free therapy sessions for children and young adults -- which were announced earlier this year -- will be extended to everyone with a doctor’s prescription. Psychiatric treatment is already largely reimbursed by the state. State healthcare systems in Britain, Germany and some other countries already fund therapy sessions. French health professionals say a national effort to improve access is long overdue, especially as the coronavirus pandemic has caused and aggravated psychological distress. *Image by mohamed Hassan from Pixabay
French Health Minister Olivier Véran has hailed the country’s Covid-19 health pass as a success, adding that similar initiatives are now being introduced in “dozens” of other countries around the world. Speaking to France 5, Mr Véran said other countries were now considering similar initiatives having seen the impact made in France. The health pass obliges people to show proof of full vaccination, a recent negative test or recent recovery from Covid-19 to be able to enter restaurants, bars and a range of other public spaces. Since the pass was announced by President Emmanuel Macron on July 12, some 12 million people (equivalent to 18% of France’s population) have been vaccinated, according to Prime Minister Jean Castex. Back in March, only 3% of the French population had been fully vaccinated against Covid-19, according to Le Monde. But this figure has now risen to 67%, highlighting how more and more people are receiving a Covid vaccine. Interestingly, take-up among the young has been particularly high considering vaccination was delayed for this group. Meanwhile, Covid health passes will no longer be required for entry into all but 64 French shopping centres this week. From Wednesday the health pass obligation will no longer apply to centres of more than 20,000 square metres in departments where the infection rate has dropped below 200 per 100,000 residents, and where cases have been falling for a week or more, Economy Minister Bruno Le Maire announced yesterday (September 6). *Image by Please Don't sell My Artwork AS IS from Pixabay
France extended its mandate to carry Covid-19 health passes to certain categories of workers as of yesterday. The move marks a new stage in the French government’s strategy to encourage members of the public to have Covid-19 vaccines. Under the new rules, staff who work face to face with the public – for example, at cafés, cinemas or on public transport – are now required to show proof that they are fully vaccinated or have tested negative for the coronavirus in the last 72 hours. Some 1.8 million workers across the country will be encompassed by the measures. Members of the public are already required to carry health passes in order to access eateries and cultural or leisure venues. While polls suggest a majority of the public supports Covid-19 health passes, their introduction has led to protests throughout the summer, with tens of thousands of protesters staging rallies across the country on consecutive weekends. The government insists the pass is necessary to encourage vaccination uptake and avoid a fourth national lockdown, with the unvaccinated accounting for most of the Covid-19 patients admitted to hospital. [Related reading: France’s COVID health passes to be made available to foreign tourists] *Image by fernando zhiminaicela from Pixabay
New Covid-19 treatments should be widely available in France before the end of the year, the head of the country's Scientific Council has predicted. According to a report in Le Parisien newspaper, Jean-François Delfraissy, an immunologist and president of the Conseil scientifique, which advises the government on medical matters, said monoclonal and polyclonal antibody treatments would be made more widely available in the coming months. Monoclonal antibody treatments are made using Covid-19 survivors’ own antibodies and are designed to fight infection just as the natural immune system would. Former US President Donald Trump received monoclonal antibody drugs when he was hospitalised with Covid-19 in 2020. At the beginning of August, French health authorities authorised the use of monoclonal antibody treatments for immuno-compromised patients who cannot be vaccinated against the virus because of their conditions. The treatments are set to be rolled out for use as required by doctors among the wider population before the end of the year. A number of pharmaceutical companies are in the process of applying for medical authorisation. They would be “effective for high-risk patients, and should reduce the number of hospitalisations”, Le Parisien reported, but would only be available under medical supervision. The drugs are intended for use in patients who are already severely ill with Covid. They do not prevent people developing the illness in the first place. *Image by Klaus Hausmann from Pixabay
The COVID-19 pandemic has rapidly accelerated digital transformation across the entire healthcare industry. That’s one of the key findings from new Google Cloud research. According to the survey of 300 US physicians, nine in 10 (90%) currently use telehealth (vs. just 32% pre-pandemic). Moreover, more than half (62%) of physicians said the pandemic forced their healthcare organization to make tech upgrades that would normally have taken several years to implement. Just under half (48%) of physicians said they would like to have access to telehealth capabilities in the next five years. However, most physicians agreed that the healthcare industry lacks behind others when it comes to digital adoption. Indeed, 64% of physicians said digital adoption was more advanced in the gaming industry, while 56% and 53%, respectively, said the telecommunications industry and financial services industry were more digitally advanced. Nevertheless, the healthcare industry’s digital adoption has improved, closing the gap on the retail, hospitality and travel, and public sectors. Google Cloud CEO, Thomas Kurian, said during a recent HIMSS21 Global Conference Digital Session: “The more efficient you can make the healthcare system, the more that healthcare system can invest back in patient care, new forms of treatment, new forms of drug discovery, et cetera.” *Image by Tumisu from Pixabay
Before the COVID-19 pandemic, ear, nose and throat (ENT) specialist Dr Clair Vandersteen might have treated around 10 patients a year for anosmia, the inability to smell. But fast-forward to today and Dr Vandersteen has seen demand for his services increase significantly. Now, the majority of his patients are those recovering from COVID-19, up to 15 a week, in fact, at the doctor’s clinic in the Centre Hospitalier Universitaire de Nice. Loss of smell is a symptom in eight out of 10 COVID-19 cases and can the effects can sometimes linger for months after the patient has recovered from the disease. “We have seen a very large increase in patients since this time a year ago,” Dr Vandersteen said. The ENT specialist says studies show that 20% of people who lost their sense of smell still had not regained it and it’s younger individuals that appear to be worst affected. “The patients we see suffering from a loss of smell are relatively young. It is predominantly a problem that affects people in their 30s and 40s.” While for some people it might seem little more than an inconvenience, Dr Vandersteen warns the condition can make patients anxious and depressed. “The loss of smell can lead to psychological problems – 30% of people who have lost their sense of smell due to Covid are suffering from some kind of psychological damage. We love eating, especially here in France, so when chocolate tastes like cigarettes, for example, it can lead to people feeling unhappy or anxious. “If you can’t enjoy the smell of your newborn baby, or the smell of your home, it can be unsettling. It can also be dangerous – if you can’t smell gas or smoke, for example.” Dr Vandersteen’s team has come up with a three-pronged approach to help. First, patients see Dr Vandersteen, who determines their level of smell loss. Then, they are seen by Auriane Gros, a doctor of neuroscience and a speech pathologist, who helps re-educate the brain to recover the perception of smells. The final step is therapy with child psychiatrist Louise-Emilie Dumas, who runs group workshops around odours. “The team has had positive results,” Dr Vandersteen says. *Image courtesy of Dr Clair Vandersteen
The UK NHS’ COVID app alerts people who have it installed to self-isolate if they have come into contact with someone who has tested positive for the coronavirus disease. But a surge in the number of notifications being received has led to a significant proportion of Brits simply switching the app off. According to a YouGov poll, one in five (20%) Brits have switched off the contract tracing function of the NHS COVID app, as the country experiences a so-called “pingdemic” of alerts. While anyone who is pinged by the app is not obliged by law to self-isolate, the UK government is strongly advising people to follow the advice to help curb COVID-19 cases. COVID-19 restrictions were recently lifted in England and since July 19, there are now no limits on how many people can meet or attend events; nightclubs have reopened; and table service is no longer necessary in pubs and restaurants. However, many other governments are looking at the UK as something of a guinea pig, having taken the decision to ease COVID restrictions despite surging numbers of delta variant cases. The UK has a relatively high vaccination rate, so it remains to be seen if that is enough to prevent the delta variant from causing significant problems. *Image by Klaus Hausmann from Pixabay
Bastille Day is France’s national day and it is celebrated every year on July 14. But how did it get its name and why is it celebrated? One of the most important national holidays for people in France, Bastille Day is celebrated in remembrance of the storming of Paris’ Bastille Prison in 1789. It was on this day when revolutionists and mutinous troops stormed and captured the military fortress and prison. The event was significant as the Bastille had become a symbol of the French king, Louis XVI’s, harsh rule and tyranny. Its fall sparked the beginning of the French Revolution, which would last for a decade and see both King Louis and his wife, Marie Antoinette, executed by guillotine in 1793. The end of the French Revolution led to the formation of the French Consulate, the top-level government of France until Napoleon declared himself emperor in 1804. Bastille Day 2021 Yesterday, in spite of the COVID-19 pandemic, people all across France recognised Bastille Day. In Paris, French President Emmanuel Macron led the national day parade, which started at the Arc de Triomphe monument and ended with a ceremony on the Concorde square. Thousands of military and public security personnel paraded by foot, on vehicles and aboard jets over Paris' Champs Elysees Avenue yesterday. You can see some coverage of the military parade in this video: https://youtu.be/hgeLhCkFBwI *Image: “Taking of the Bastille” by Rama, Wikimedia Commons, Cc-by-sa-2.0-fr
France’s healthcare system is to benefit from €7bn worth of investment, which is designed to drive innovation in the sector. Speaking at the end of June, French President Emmanuel Macron announced that public funding would be made available in the wake of the COVID-19 pandemic in the country. Part of France’s Health Innovation Plan 2030, €2bn will be invested by the state-owned Banque Publique d'Investissement (BPI) in start-ups and small and medium-sized companies (SMEs) in the healthcare industry. France will also invest €2bn in research for emerging and infectious diseases, biotherapies and digital health. Following the COVID-19 pandemic, the plan will allocate almost €750 million for emerging infectious diseases and CBRN (nuclear, radiological, biological and chemical) threats. Another €800m will be dedicated to biotherapies and the bioproduction of innovative therapies that represent 50% of the clinical trials currently underway. These technologies enable the development of so-called personalised medicine by providing therapeutic solutions in oncology, immunology, virology and for rare diseases, for example. President Macron wants to make France the leading European country in healthcare innovation by 2030. He has committed to lift administrative hurdles to speed up organisational changes in the healthcare system. *Image by Parentingupstream from Pixabay
Telemedicine, also known as telehealth, is something many people have experienced during the COVID-19 pandemic. It is something that has really come into its own, helping patients connect with their clinicians at a time when just leaving the house presented a challenge. Now, another form of virtual healthcare, teledentistry, is emerging as another potential disruptor in the healthcare space. Predicted to witness spectacular growth of 16.6% from 2020-2027 to reach US$ 920.83million in 2027 from US$ 242.51million in 2019, the European teledentistry market looks set to achieve spectacular results. But it’s not just in Europe where teledentistry is taking off. According to a report in the Tyler Morning Telegraph, Texas Governor Greg Abbott recently signed a bill into law formally ending a ban on teledentistry in the state. The new law comes months after a lawsuit was filed by the Pacific Legal Foundation and after bipartisan calls for reform were made. Under the new law, the Texas State Board of Dental Examiners will not be allowed to ban teledentistry, bringing it in line with other telemedicine practices. Abbott previously signed a bill into law expanding and making some telemedicine services permanent. “This is great news for Texas citizens who will continue to have access to quality dental care from the comfort of their homes,” Joshua Polk, an attorney at Pacific Legal Foundation, said. The foundation represented teledentistry providers who challenged the Texas Board of Dental Examiners’ ban. “There is a crisis in dental care access in Texas, and this legislation will go a long way in addressing that crisis,” he added. “It will also allow our clients to continue operations in the state.” *Image by Rafael Juárez from Pixabay
On Tuesday, France lowered the age of eligibility for COVID-19 vaccines to 12, opening the door for millions of French children to receive a boost to their resilience to the coronavirus pandemic. Perceval Gete, a 12-year-old French boy from the suburb of Vitry-sur-Seine, was one of the youngest people in Europe to receive a COVID-19 vaccination, according to reports. To accommodate his young age, the nurse administering the jab had to use a special child-size needle. “I wanted it to be done as soon as possible,” his mother, Melanie Gete, said at the vaccination center in the suburb of Vitry-sur-Seine after Perceval had the jab. Prior to the rule change, people in France had to be at least 18 years old, or 16 if they had underlying conditions, to be eligible to receive a COVID-19 vaccination. Now, providing they have parental consent, children as young as 12 can be vaccinated. In wealthy countries worldwide, governments have been expanding their vaccination programs to include younger people, who, it is worth noting, are less likely than older individuals to get seriously ill from COVID-19. However, France’s limit of 12 years is one of the lowest of any major European Union state. Nurse Aurelie Job, who administered the vaccine to Perceval Gete on Tuesday, used a needle that is around half the length of the standard size used for adults. “Children have smaller arms so we need smaller needles to vaccinate children,” she said. “It prevents us from touching the bone while vaccinating children, and it’s less upsetting for them.”
Last year, makeshift terraces sprang up on many cafes across Paris, allowing COVID-wary patrons to be served outdoors. Now, city hall has announced these ‘Covid terraces’ will become a permanent fixture in the French capital this summer. In response to the impact of the pandemic on beleaguered restaurant and café owners who were no longer allowed to serve indoors, the city of Paris turned over thousands of parking spaces to enable establishments to continue serving drinks and food outdoors. Many establishment owners invested in high-quality structures in the spaces, which are still usable today. Terraces will have to remain without closed walls and plants and other greenery will be encouraged. "Roofs, tarps, reception tents, wooden pallets and advertising will be prohibited," the deputy mayor in charge of commerce, Olivia Polski, told AFP. There will also be a requirement for them to shut down by 10:00pm, so that local residents won’t be disturbed by any noise. The city will hold an annual contest for the most attractive designs, a move clearly aimed at encouraging aesthetically pleasing structures. Outdoor seating can also be extended on adjacent squares and sidewalks, and also in front of neighbouring businesses, providing they give approval. No heating or music systems will be allowed, and Polski said the city would step up deployments of specially developed "Meduse" microphones for pinpointing the sources of noise pollution across the city. Outdoor drinking and dining resumed across France last month as France emerged from its third wave of coronavirus cases, a huge relief for restaurants and bars closed since last October. On Wednesday, restaurants and cafés will be allowed to start serving indoors and the nationwide curfew will be pushed back to 11:00 pm, which is expected to further swell the summer sidewalk crowds. *Image: Lucas BARIOULET AFP/File
The American Academy of Sleep Medicine has published an update in the Journal of Clinical Sleep Medicine stating that, during the pandemic, telemedicine has been an effective tool for the diagnosis and management of sleep disorders. Since the academy’s last update in 2015, the use of telemedicine services has increased exponentially as a result of the COVID-19 pandemic. The academy’s latest update adds that the COVID-19 pandemic has highlighted telemedicine’s ‘importance in improving access to sleep care and advocating for sleep health.’ Furthermore, a growing body of published research has found telemedicine to be effective in the management of patients with sleep disorders, such as apnea, and for the delivery of cognitive behavioral therapy for the treatment of insomnia. The update authors also outlined how a shortage of trained behavioral sleep therapists has led to the development of online application-based CBT-I programs and a recent systematic review and meta-analysis found that internet-delivered CBT-I is effective in improving sleep. Telemedicine, the academy says, is also effective for helping to treat sleep disorders among children: ‘Telehealth follow-up visits, primarily via telephone, have been used for chronic management of obstructive sleep apnea and internet delivered CBT-I has been shown to be effective in adolescents with insomnia.’ *Image by Claudio_Scott from Pixabay
Nearly three years after it was cancelled, the night train service from Paris to Nice has returned, part of a broader push by the French Government to promote more environmentally friendly means of transportation. First introduced in the late 1800s, the Paris-Nice night train, colloquially known as ‘Le Train Bleu’, was a luxury sleeper service, internationally famed for its list of wealthy and famous passengers. However, during the 1980s, when high-speed TGV trains proliferated and cut the travel time from Paris to Nice from 20 hours down to just five, the era of luxury night trains to the French Riviera was effectively ended. While Le Train Bleu would continue its service for a few more decades, it ceased to exist under than name in 2003. Then, in Dece3mber 2017, it was discontinued completely due to the French Government withdrawing its funding. But now it’s back. Under the French Government’s pandemic plans to encourage more eco-friendly transport as part of its broader economic relaunch packages, the sleeper service from Paris to Nice is back. The first Paris-Nice night train departed Paris Austerlitz station at 20:52 on May 20 and arrived in Nice at 09:11 on May 21. To highlight just how much attention the sleeper service re-launch attracted, French Prime Minister Jean Castex was among the passengers, At a time when France is striving hard to bring down its carbon emissions, night trains are also more "virtuous" than cars or planes, as Castex's office told AFP. The night train will run daily between Paris and Nice in both directions. And while it takes twice as long as the TGV to complete the nearly 1,088-kilometre (675-mile) voyage, it’s a lot more affordable. Paris-Nice TGV tickets usually cost well over 100 euros one-way. Night train prices start from just 29 euros. *Image: Le Train Bleu in the Gare de Lyon, Paris, courtesy of Gryffindor and licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
Prior to the Covid-10 pandemic, medical tourism was one of the fastest-growing industries in the world. Indeed, according to Grand View Research, the global medical tourism market size was valued at US$44.8 billion in 2019, with compound annual growth of 21.1% expected between 2020 and 2027. However, the global SARS-CoV-2 outbreak has significantly impacted travel abroad. Luckily, we are seeing signs that things are slowly returning to normal. [Related reading: France to offer free Covid-19 tests to tourists this summer] Now, something that has come into its own during the coronavirus pandemic is telehealth. In fact, data shows usage of telehealth services has increased by more than 2,000% since 2019. But what’s going to happen to telehealth services once “normal” travel resumes? We believe they’ll still play a pivotal role, particularly when it comes to complementing medical tourism. With telehealth, patients can have consultations with specialists on the other side of the world, negating the need to travel in the first instance. If the patient and clinician agree that travel for surgery or other healthcare is necessary, telehealth can continue to afford benefits, including: - Improve the quality and efficiency of customer service by helping to coordinate care between providers in the patient’s home country and the medical tourism destination - Enhance pre-operative and post-operative care - Optimize patient and family member travel. If you’d like to find out more about our telehealth services and/or how we can help you get any medical treatment you need in France, get in touch today. *Image courtesy of mohamed Hassan from Pixabay
Parisian catwalks will reopen from July as the French government looks to wind down Covid-19 restrictions, paving the way for live fashions show to resume, the country's fashion industry body announced on Tuesday (May 11). The annual Haute Couture Week — which sees a select club of designers display one-of-a-kind, handmade outfits — will take place from July 5 to July 8 and fashion houses will be allowed to organise live shows and presentations, according to a statement from the French fashion industry body Federation De La Haute Couture Et De La Mode Depending on how the pandemic progresses, physical fashion shows with live guests would be allowed, in line with government guidance on public events. No major live fashion shows have been held in Paris since September 2020. Back then, some brands, including Dior and Chanel, organised a few shows with live audiences, but with a strictly limited number of guests. In the past months, fashion brands have presented their new lines in online-only shows and have experimented with other ways to showcase their designs such as short films and one-on-one presentations. The federation said its Haute Couture online platform https://hautecouture.fhcm.paris/fr would remain available for digital-only shows going forward and would also retransmit the physical shows. Prior to the Covid-19 pandemic, Paris’ multiple fashion weeks generated some 1.2 billion euros for the local economy every year, the federation grouping couture houses estimates. *Image courtesy of Pexels from Pixabay
Telemedicine will save the healthcare industry a staggering $21 billion in costs by 2025, new research suggests. This represents an increase of over 80% in the next four years, rising from $11 billion in 2021. According to the study by Juniper Research, teleconsultations, a service that enables patients and physicians to interact remotely with patients, will play a key role in enabling these significant savings. However, Juniper cautioned that such savings would be restricted to developed countries where people have access to required devices and suitable Internet connectivity. Indeed, Juniper predicts that North America and Europe will realise over 80% of savings by 2025. The Jupiter report also reveals how telemedicine usage has soared as a result of the coronavirus pandemic, with remote consultations rising from over 280 million in 2019, to 348 million in 2020. By taking advantage of telehealth solutions, doctor’s offices have been able to significantly reduce the number of face-to-face appointments they’ve needed to accommodate, cutting the risk of waiting room Covid-19 infections. However, the report did warn that the significant investment required and obligation to abide by data protection laws, such as the US’s Health Insurance Portability and Accountability Act (HIPAA), could discourage telemedicine adoption among smaller healthcare providers. “Any deregulation must ensure that patient confidentiality is not undermined,” said research author Adam Wears. “Additionally, we recommend that innovative and emerging teleconsultation services are integrated into existing healthcare technologies, such as electronic health records, to maximise their benefits to healthcare providers.” Jupiter Research’s report, Telemedicine: Emerging Technologies, Regional Readiness & Market Forecasts 2021‑2025, is available here: https://www.juniperresearch.com/researchstore/key-vertical-markets/telemedicine-research-report *Image by Tumisu from Pixabay
France has granted citizenship to more than 2,000 foreign-born frontline workers as a reward to them for their services to the country throughout the ongoing coronavirus pandemic. Marlene Schiappa, junior interior minister in charge of citizenship, said that 2,009 people, including 665 children, had been fast-tracked for naturalisation for "showing their attachment to the nation". Back in September, Schiappa instructed citizenship authorities to speed up the applications of essential workers who had "actively contributed" in the fight against Covid-19. She ordered that they be allowed to apply for citizenship after just two years in France. Normally, under French Nationality Law, a person can apply for French citizenship by naturalization after five years' habitual and continuous residence in the country. Among the more than 2,000 individuals granted citizenship are health workers, security guards, checkout workers, garbage collectors, home-care providers and nannies. Schiappa's office said that over 8,000 people have applied for citizenship under the scheme, adding that all requests were being given "the greatest consideration". In 2020, 61,371 people were granted French citizenship, a decline of 20% compared with 2019. [Related reading: Covid -19 lockdown lifting in France: bars, restaurants, museums and cinemas to reopen May 19] *Image courtesy of mohamed Hassan from Pixabay
During the coronavirus pandemic, eligible Australians have been accessing Medicare-subsidised telehealth services. However, this arrangement is due to end on June 30. But it now looks like there will be an extension until at least the end of the year. Australian Health Minister, Greg Hunt, has said the government will extend Medicare-subsidised telehealth services until the end of the year, while the government works with peak bodies to design a post-pandemic telehealth system going forward “Over the last 12 months, telehealth services have been life-changing for many in need of support,” Mr Hunt said. “The extension will ensure that Australians can continue to see their GP, renew scripts and seek mental health support from the safety of their own home. This allows vulnerable Australians to feel protected and supported during these unprecedented times.” The Australian Government rapidly rolled out telehealth subsidies back in March 2020 when the coronavirus pandemic became apparent to enable citizens to continue to access GP, mental health and allied health services even during lockdowns. Over the course of the year to the end of March, more than 54 million Medicare-subsidised telehealth services were delivered to 13.5 million patients. The cost of the six-month extension will be detailed in the Australian federal budget on May 11, 2021. *Image: Sydney Opera House, courtesy of Patty Jansen from Pixabay
France has become the first European country to begin testing a digital Covid-19 travel certificate as part of a Europe-wide scheme which Brussels hopes will allow more freedom of travel within the bloc by the summer. The testing will be conducted through France’s TousAntiCovid app, part of the country’s contact tracing programme, which has been upgraded to allow it to store negative Covid-19 test results on travellers’ mobile phones. The app is being trialled on flights to Corsica and overseas départements from this week. According to a French official, at first, the certificates will only be used for travel, but they “could eventually be adopted for public events such as concerts, festivals and trade fairs,” although not for bars and restaurants. The app has so far been downloaded by nearly 15 million French citizens. The French trial will form one part of a “reinforced, consolidated and standardised” Europe-wide system, the minister for digital transition, Cédric O, said. Talks are already underway with several countries and airlines to ensure early recognition. The European commissioner for justice, Didier Reynders, said last week he expected the EU’s “digital green certificate” to be operational by 21st June. The certificate is an urgent priority for southern European member states whose economies have been hit hard by the coronavirus pandemic. *Image by Pexels from Pixabay
As we highlighted in a previous blog post, telehealth/telemedicine services have come into their own during the Covid-19 pandemic, allowing patients to connect with their clinicians in a way that’s fast, convenient and safe. However, remote consultations often have their limitations, including how to perform diagnostic tests and take medical measurements. But now researchers from the University of Washington have devised a way to measure patients' pulse and breathing rates via a smartphone's camera. The researchers say the advancement will make telehealth more accurate and useful. According to UW News, the system, called MetaPhys, can detect a patient’s pulse or respiration rate using in real-time using video of their face. "Machine learning is pretty good at classifying images. If you give it a series of photos of cats and then tell it to find cats in other images, it can do it," Xin Liu, the study's lead author and a student in the Paul G. Allen School of Computer Science & Engineering doctoral student, told UW News. "But for machine learning to be helpful in remote health sensing, we need a system that can identify the region of interest in a video that holds the strongest source of physiological information — pulse, for example — and then measure that over time." The team's original iteration of MetaPhys was presented last December at the Neural Information Processing Systems conference. However, the first iteration had some pitfalls, most notably that it struggled with certain lights, backgrounds and skin colors. The second version, the researchers say, improves upon the first and overcomes these limitations. *Image courtesy of tookapic from Pixabay
Prior to the Covid-19 pandemic, telehealth/telemedicine services were more of a convenience than a necessity for most patients. They offered (and still do offer) a way for a patient to consult with their clinician without having to make a trip to the doctor’s office. But it was when the Covid-19 pandemic struck that telehealth really came into its own, with more patients than ever taking advantage of such services to receive non-emergency healthcare from the safety of their own homes. Now, new research from Sykes reveals that most consumers – having experienced telehealth services during the pandemic -- want them to remain post-Covid. According to the Sykes survey, which polled 2,000 Americans in March on how their opinions on virtual care have changed within the past year, more than 61% had undergone a telehealth visit come March this year. In comparison, less than 20% had utilized telehealth by March 2020. Furthermore, in March 2020, around 65% of Americans felt hesitant or doubtful about the quality of telehealth services, while 56% did not believe they could afford the same level of care compared to in-person appointments. However, now, almost 88% want to continue using telehealth for non-urgent consultations after the COVID-19 pandemic has ended. Moreover, almost 80% agree it's possible to receive quality care via telehealth services. *Image by Tumisu from Pixabay
Telehealth services have really come into their own during the coronavirus pandemic, offering a way for patients and clinicians to have consultations without the need for a face-to-face meeting. Now, a group of inventors at the University of Cincinnati (UC) want to take telehealth consultations to another level by facilitating them to be performed via drone. The technology aims to fill the gap in telehealth delivery among those who do not own or have access to the devices, such as smartphones, computers and internet connectivity, that are required for telehealth consultations. Inventors Victoria Wangia-Anderson, Manish Kumar, Seung-Yeon Lee and Debi Sampsel from three colleges at UC collaborated to develop a semi-autonomous prototype that can be dispatched right to people’s homes. The drones are capable of carrying certain medical equipment and supplies, but remain agile enough to navigate the tight spaces found in homes. A variety of health assessments can be conducted using the telehealth drones, including taking temperatures and measuring oxygen levels. The drone kits also include patient-friendly devices, and the clinician will be able to instruct patients on how to use them. Patients who require assistance can also seek help from family or other caregivers during the drone sessions. Speaking about the telehealth drones, Debi Sampsel, director of telehealth at UC’s College of Nursing, said: “We can perform all kinds of functions: chronic disease management, post-operative care monitoring, health coaching and consultations,” she said. “And in the health care arena, there is no age limit. Telehealth services are useful from birth to death.” Find out more via the University of Cincinnati website. *Image courtesy of Joseph Fuqua II/UC Creative + Brand for the University of Cincinnati
France is gearing up for a possible easing of COVID-19 lockdown restrictions from mid-April, as vaccines, to date, are proving effective at lowering infection rates. French government spokesman Gabriel Attal said on Wednesday that while the nation is still facing hard times, “For the first time in months, the return to more normal living conditions is in sight.” Attal said vaccinated groups (mainly the elderly) are witnessing falling infection rates, which, he said, is a sign that the country’s vaccination program is working and should be sped up. "It is neither a distant nor uncertain horizon - it is an horizon that is getting closer and closer. We hope maybe from mid-April, and we are preparing for it. "The president (Emmanuel Macron) asked us to submit proposals that could allow for a cautious re-opening of the country soon,” he said. Attal added that the goal of vaccinating the most fragile was to reduce hospitalizations and safeguard the nation’s health care system, which is key to easing restrictions. Earlier this week, Health Minister Olivier Veran said France will retain its current measures aimed at limiting the spread of COVID-19, including a nighttime curfew, as a bare minimum for the next four to six weeks. Other measures now in force include the closure of bars, restaurants, museums, sports and music venues. COVID-19 is the disease caused by the coronavirus.
People in France aged over 65 with existing health problems will be allowed to be given the AstraZeneca COVID-19 vaccine, after the French Government reversed its policy. When the AstraZeneca vaccine was approved for use by European Union regulators, the French Government said it should only be given to eligible people under 65 because data from trials in older age groups was limited. The AstraZeneca vaccine will now be offered to people up to the age of 74. However, the shot has been hit by a slow rollout and a lack of trust. French Health Minister Olivier Veran said Monday: "Anybody aged 50 or over who is affected by co-morbidities can get the AstraZeneca vaccine, including those between 65 and 74." The announcement has the potential to affect more than two million people. British health authorities released new data on Monday that showed the AstraZeneca vaccine reduced hospitalization from COVID-19 by more than 80%. The vaccine is widely used in the UK but has missed delivery targets in the EU. People aged 75 and over would continue to get the Pfizer and Moderna vaccines only, Veran said. Meanwhile, Germany still hasn’t cleared the AstraZeneca vaccine for over 65s. This has led to fewer people stepping up for the shot and several doses being wasted. Image courtesy of Marco Verch on Flickr, licensed under the Creative Commons Attribution 2.0 Generic (CC BY 2.0)
The COVID-19 pandemic has caused telehealth to become a bigger economic development concern among local areas. That’s one of the key findings of new research by broadband industry analyst Craig Settles. According to Settles’ Broadband, Local Economies, & the Age of Covid survey -- which polled 200 professionals from economic development departments within local and state governments and economic development agencies across the United States – 40% of respondents indicated that telehealth can have a “measurable impact” on their local economy in terms of attracting medical professionals and reducing unnecessary ER visits. When the same survey was conducted two years ago (in 2019), only about 25% of respondents said the same about telehealth’s potential impact on the medical workforce and ER visits. Moreover, more respondents this year said telehealth can help more mental health services remain local, as well as keep senior citizens living at home longer. Settles says these findings suggest there is money to be made and saved by boosting telehealth capabilities. Specifically, he sees a lot of potential value in local telehealth radiology programs, citing the $1.8 million saved over 10 years by a radiology practice in Chattanooga, Tennessee. “There are serious dollars and cents to be had if you can do this locally, because people don’t have to go all the way to China to get their X-rays, all the various MRIs and so forth,” Settles said. “The forward-thinking communities, especially if they’re a rural area, I would look at starting a radiology practice because there’s money to be made there locally. Obviously, you can’t do this without broadband, but if you’re one of these cities building the network, that should be a main consideration for revenue.”
A single dose of Pfizer/BioNTech’s Covid-19 vaccine reduces a person’s risk of infection by 72%, a new study has revealed. According to Public Health England (PHE), the first dose of the Pfizer/BioNTech Covid-19 vaccine "provides high levels of protection against infection and symptomatic disease.” PHE's Siren Study, which involved healthcare workers aged under 65, found that one dose of the Pfizer/BioNTech Covid-19 vaccine reduced the risk of infection by 72% after three weeks. Two doses of the vaccine reduced the risk of infection by 85%. This high level of protection also includes the B.1.1.7 coronavirus variant first identified in the UK in December. For the study, health workers were tested for Covid-19 infection every two weeks using PCR tests and twice a week with lateral flow tests. As Dr. Susan Hopkins, strategic response director at PHE, explained, "there was a lot of asymptomatic testing.” "Overall we are seeing a really strong effect to reducing any infection: asymptomatic and symptomatic," Hopkins said during a press conference held by the UK's Science Media Centre on Monday. Promising early data has also shown that people who are vaccinated and subsequently catch Covid-19 are far less likely to die of, or be hospitalized with, the virus. For example, people over the age of 80 who were infected after being vaccinated were 41% less likely to be hospitalized with the virus and 57% less likely to die of it.
The World Health Organization (WHO) yesterday gave two versions of the AstraZeneca/Oxford COVID-19 vaccine the green light to be used for emergency use, listing them on its Emergency Use Listing (EUL), paving the way for them to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. WHO’s EUL assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. “Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products. ‘But we must keep up the pressure to meet the needs of priority populations everywhere and facilitate global access. To do that, we need two things – a scale-up of manufacturing capacity, and developers’ early submission of their vaccines for WHO review.” Pfizer/BioNTech’s vaccine was listed for emergency use by WHO on 31 December 2020.